ASCO approaches, and the season of cancer vaccine hype is upon us.
Exhibit A: Cleveland Clinic Researchers Develop Prototype Vaccine To Prevent Breast Cancer. That's the headline for this press release from the Cleveland Clinic's Lerner Research Institute, announcing a Nature Medicine letter, and featuring the quote below.
"We believe that this vaccine will someday be used to prevent breast cancer in adult women in the same way that vaccines prevent polio and measles in children," said Vincent Tuohy, Ph.D., the study's principal investigator and an immunologist in Cleveland Clinic's Lerner Research Institute Department of Immunology. "If it works in humans the way it works in mice, this will be monumental. We could eliminate breast cancer."PR folks: you know you're hypey when even the Daily Mail takes a more measured tone in its headline. As blogger/consultant/sane person Sally Church points out, the drug development road and the odds are very long indeed. "Please, show us some solid DATA first before hyping a theory all over the internets, however well intentioned," she concludes.